Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Novavax Shares Jump on NIH Swine Flu Agreement

By Pharmaceutical Processing | June 4, 2009

NEW YORK (AP) — Novavax Inc. stock surged Thursday after the company said it is working with the National Institutes of Health to evaluate a potential swine flu vaccine. The Rockville, Md.-based company said its scientists produced a virus-like particle in May. The particle is similar in size and structure to particles of the swine flu, but they don’t have the genes needed to replicate. Novavax developed the particle to provoke an immune response against the swine flu in the human body. Novavax also is working with the Division of Microbiology and Infectious Disease, which is part of the National Institute of Allergy and Infectious Diseases. In a note to clients, Rodman & Renshaw analyst Elemer Piros said he expects human trials of the vaccine to begin in late August, and finish in time for flu season at the end of the year. Piros said the NIH could start stockpiling the vaccine before testing is complete. In afternoon trading, shares of Novavax climbed $1, or 53.5 percent, to $2.87. Trading volume was several times the stock’s daily average. Novavax is the second company to announce in recent weeks that it is working on a swine flu vaccine candidate. On May 21, Vical Inc. said it had started testing a protoype vaccine on animals. Vical is developing the vaccine under an agreement with the U.S. Navy.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE